Optical Imaging Market (2013-2018) - Technology Trends And Applications of OCT, HSI, NIRS and PAT in Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018
|出版日||ページ情報||英文 147 Pages
|世界の光学画像市場の見通し：臨床診断・臨床研究・ライフサイエンスにおけるOCT・HIS・NIRS・PATのアプリケーションと技術動向 Optical Imaging Market (2013-2018) - Technology Trends And Applications of OCT, HSI, NIRS and PAT in Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018|
|出版日: 2013年03月04日||ページ情報: 英文 147 Pages||
Title: Optical Imaging Market (2013-2018) - Technology Trends and Applications of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) and Photo- Acoustic Tomography (PAT) in Clinical Diagnostics, Clinical Research and Life Sciences with Market Landscape Analysis - Estimates Up to 2018.
Optical Imaging is an emerging medical technology that uses light to assess optical properties of tissues, and has a great potential for improving disease prevention, clinical research, medical diagnosis and treatment. The basic principle involves - the detection of emitted photons at pre-defined wavelength ranges when the fluorescent probes in the optical imaging system can be excited by NIR light. Further advancements and breakthroughs in the field of fiber optics and photonics resulted in the emergence of innovative technologies such as Optical Coherence Tomography (OCT), Photo-Acoustic Tomography (PAT), Hyper-Spectral Imaging (HSI) and Near-Infrared Spectroscopy (NIRS) that have a potential to redefine the fields of clinical diagnostics and research. These technologies have an ability distinguish the diverse soft tissues based on photon absorption and scattering differences among the soft tissues enhancing the accuracy of clinical research and pathological diagnosis. Though these technologies are still in the early phase of development, they offer a number of advantages (such as non-invasiveness and use of no ionizing radiation) over existing radiological screening techniques.
This research report is categorized into OCT, PAT, HSI and NIRS and is further classified as follows:
Source: MarketsandMarkets Analysis
Global optical imaging market is anticipated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major markets followed by Europe, and have been driving the market significantly owing to the increase in aging population across the developed economies. Emerging economies such as Asia-pacific and Middle-East are the future drivers of this market.
Source: MarketsandMarkets Analysis
This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service.
Multi-modality imaging using fibre-optics principles boosts the development of novel therapeutics and early detection of chronic diseases. Advancements in these modalities enable clinicians to visualize better views of anatomical structure and function, both at the molecular and cellular levels.
A key driving force is the technology's immense application scope for easy access to visualize and image in-depth structures of eye, surface tissues, mucosal membranes, the gastrointestinal tract, and vascular systems. They also enhance the drug discovery process by enabling better imaging of tissues and other biological entities at the molecular level. A major advantage of using optical imaging includes operator safety, patient comfort and patient safety. In the future, most of these technologies will gain widespread clinical acceptance and find specific roles in the clinical medicine.
The key players profiled in the report are Michelson Diagnostics, Heidelberg Engineering GmBH, Carl Zeiss Meditec, Volcano Corporation, Topcon Medical Systems Inc., St. Jude Medical Inc., Headwall Photonics, Cytoviva Inc., ChemImage Corporation, Bioptigen Inc., Raytheon ELCAN Optical Technologies, Somanetics Corporation and ASE Optics Inc.
The research service on “Advances in Optical Imaging in Clinical Diagnostics & Clinical Research - Technology Trends and Market Landscape Analysis” is an attempt to showcase the technology and market impact of existing and emerging fibre-optics based technologies having an immense growth potential in clinical medicine for the next five years. This technology based research report categorizes optical imaging market based on technology, applications and based on geography.
The report covers the technical aspects of OCT, PAT, NIRS and HSI along with investment potentials. Quantitative data analysis and growth rates of OCT are provided for the North America and European regions and potential addressable market for other technology segments are mentioned in the report.
The technologies in this report were thoroughly based on geographies -North America, Europe, Asia, and Rest of the World (ROW) providing in-depth information on market size, share and segmentation. The report also provides information on adoption and development potential of OCT, HSI, NIRS and PAT technologies in these regions.
This report service on optical imaging in clinical medicine comprehends 75% of its focus on technological understanding and 25% of market engineering standards. There is only one recent available report on Optical Imaging Devices and it does not include market numbers. So this report would be the first holistic report which analyses in depth about technology as well as market landscape of optical imaging market.